Efficacy and Safety of Eptinezumab in Patients With Chronic Migraine: PROMISE-2

Neurology. 2023 Aug 8;101(6):283. doi: 10.1212/WNL.0000000000207168. Epub 2023 Apr 4.
No abstract available

Publication types

  • Published Erratum